Clinical Trial Update: EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations [NA]

View source ↗

Summary

This document provides an update on the EQUAL trial evaluating EGFR ctDNA quantitative assessment for lung cancer screening in Asian and Latinx populations, whi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Lung Cancer, EGFR Gene Mutation | NA | Status: RECRUITING